Send me a link:

*Text messaging rates may apply.

 Dow Down0.16% Nasdaq Up0.40%

Synageva BioPharma Corp. (GEVA)

-NasdaqGS
72.44 Up 1.02(1.43%) 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 13,374   14,954   2,099  
Cost of Revenue -   -   -  
Gross Profit 13,374   14,954   2,099  
Operating Expenses
Research Development79,644  37,347  17,346  
Selling General and Administrative27,560  17,396  9,268  
Non Recurring -   -   -  
Others2,073  3,232  504  
Total Operating Expenses -   -   -  
Operating Income or Loss (95,903) (43,021) (25,019)
Income from Continuing Operations
Total Other Income/Expenses Net159   -  (259)
Earnings Before Interest And Taxes(95,402)(42,949)(25,306)
Interest Expense -   -   -  
Income Before Tax(95,402)(42,949)(25,306)
Income Tax Expense48   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(95,450)(42,949)(25,306)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (95,450) (42,949) (25,306)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (95,450) (42,949) (25,306)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.